RNA-targeted therapeutics

ST Crooke, JL Witztum, CF Bennett, BF Baker - Cell metabolism, 2018 - cell.com
RNA-targeted therapies represent a platform for drug discovery involving chemically
modified oligonucleotides, a wide range of cellular RNAs, and a novel target-binding motif …

Redox homeostasis and cellular antioxidant systems: crucial players in cancer growth and therapy

B Marengo, M Nitti, AL Furfaro, R Colla… - Oxidative medicine …, 2016 - Wiley Online Library
Reactive oxygen species (ROS) and their products are components of cell signaling
pathways and play important roles in cellular physiology and pathophysiology. Under …

Effects of molecular crowding on the structures, interactions, and functions of nucleic acids

S Nakano, D Miyoshi, N Sugimoto - Chemical reviews, 2014 - ACS Publications
Nucleic acids are excellent at recognizing complementary sequences through the formation
of Watson− Crick base pairs. Since the base pairing enables the highly selective …

Protein kinase C, an elusive therapeutic target?

D Mochly-Rosen, K Das, KV Grimes - Nature reviews Drug discovery, 2012 - nature.com
Protein kinase C (PKC) has been a tantalizing target for drug discovery ever since it was first
identified as the receptor for the tumour promoter phorbol ester in 1982. Although initial …

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

PJ Roberts, CJ Der - Oncogene, 2007 - nature.com
Mitogen-activated protein kinase (MAPK) cascades are key signaling pathways involved in
the regulation of normal cell proliferation, survival and differentiation. Aberrant regulation of …

Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression

N Isakov - Seminars in cancer biology, 2018 - Elsevier
The AGC family of serine/threonine kinases (PKA, PKG, PKC) includes more than 60
members that are critical regulators of numerous cellular functions, including cell cycle and …

Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.

F Chang, LS Steelman, JT Lee… - Leukemia …, 2003 - search.ebscohost.com
Abstract The Ras/Raf/Mitogen-activated protein kinase/ERK kinase (MEK)/extracellular-
signal-regulated kinase (ERK) cascade couples signals from cell surface receptors to …

Issues and progress with protein kinase inhibitors for cancer treatment

J Dancey, EA Sausville - Nature reviews Drug discovery, 2003 - nature.com
Identification of the key roles of protein kinases in cancer has led to extensive efforts to
develop kinase inhibitors for the treatment of a wide range of cancers, and more than 30 …

The urokinase plasminogen activator system: a target for anti-cancer therapy

S Ulisse, E Baldini, S Sorrenti… - Current cancer drug …, 2009 - ingentaconnect.com
The urokinase plasminogen activator (uPA) system (uPAS) consists of the uPA, its cognate
receptor (uPAR) and two specific inhibitors, the plasminogen activator inhibitor 1 (PAI-1) and …

[HTML][HTML] Raf kinases: function, regulation and role in human cancer

DT Leicht, V Balan, A Kaplun, V Singh-Gupta… - … et Biophysica Acta (BBA …, 2007 - Elsevier
The Ras-Raf-MAPK pathway regulates diverse physiological processes by transmitting
signals from membrane based receptors to various nuclear, cytoplasmic and membrane …